Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

Anxiety emerges early in patients with Parkinson's Disease, and not just as an emotional response to a difficult ...

A team of neuroscientists in Australia has found that restoring copper levels in the brain dramatically reduced Parkinson-like damage in mice. The approach restored a protein’s function, and the same ...

Parkinson’s disease often starts on one side of the body, and new research shows this asymmetry influences how non-motor symptoms progress.

The vascular parkinsonism market is forecasted to grow from USD 319.5 million in 2025 to USD 538.1 million by 2035, at a CAGR of 6.20% during the forecast period. The growth is being driven by the ...

A cancer immunotherapy may slow Parkinson’s disease by blocking the spread of harmful brain proteins, Johns Hopkins researchers found.

Clayton Strong had a history of domestic unrest in two marriages. The women’s families say a more thorough investigation of Betty Strong’s death in Idaho might have saved the life of his next wife, ...

VY1706, an IV-delivered tau silencing gene therapy that has shown up to 73% knockdown of tau mRNA in non-human primates following a single IV dose and is advancing towards IND in 2026.

People with Parkinson's disease living in Northern NSW will continue to have access to specialist support, with Northern NSW Local Health District ...

Researchers have discovered how a surface protein on brain cells, called Aplp1, can play a role in spreading material ...

Tau protein is essential for microtubule stability and neuronal function. The protein’s disfunction is linked to several ...